DK0578768T3 - Nedsvælgelige farmaceutiske sammensætninger til behandling af lidelse i den øvre del af mavetarmkana len - Google Patents

Nedsvælgelige farmaceutiske sammensætninger til behandling af lidelse i den øvre del af mavetarmkana len

Info

Publication number
DK0578768T3
DK0578768T3 DK92910661.5T DK92910661T DK0578768T3 DK 0578768 T3 DK0578768 T3 DK 0578768T3 DK 92910661 T DK92910661 T DK 92910661T DK 0578768 T3 DK0578768 T3 DK 0578768T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
upper gastrointestinal
deductible
treatment
gastrointestinal disorders
Prior art date
Application number
DK92910661.5T
Other languages
Danish (da)
English (en)
Inventor
James Grigg Upson
Carmelita Macklin Russell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK0578768T3 publication Critical patent/DK0578768T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK92910661.5T 1991-04-04 1992-03-13 Nedsvælgelige farmaceutiske sammensætninger til behandling af lidelse i den øvre del af mavetarmkana len DK0578768T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68045991A 1991-04-04 1991-04-04

Publications (1)

Publication Number Publication Date
DK0578768T3 true DK0578768T3 (da) 1996-02-05

Family

ID=24731206

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92910661.5T DK0578768T3 (da) 1991-04-04 1992-03-13 Nedsvælgelige farmaceutiske sammensætninger til behandling af lidelse i den øvre del af mavetarmkana len

Country Status (16)

Country Link
EP (1) EP0578768B1 (de)
JP (1) JPH06506682A (de)
KR (1) KR100238565B1 (de)
AT (1) ATE128351T1 (de)
AU (1) AU665349B2 (de)
BR (1) BR9205827A (de)
CA (1) CA2106215C (de)
CZ (1) CZ282105B6 (de)
DE (1) DE69205158T2 (de)
DK (1) DK0578768T3 (de)
ES (1) ES2077417T3 (de)
GR (1) GR3017580T3 (de)
HU (1) HU213203B (de)
RU (1) RU2126249C1 (de)
SK (1) SK121293A3 (de)
WO (1) WO1992017164A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0662840A1 (de) * 1992-10-09 1995-07-19 The Procter & Gamble Company Pharmazeutische Zusammensetzung und Methode zur Behandlung von Schnupfen
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
WO1994025009A1 (en) * 1993-04-30 1994-11-10 The Procter & Gamble Company Coated pharmaceutical compositions
CA2163003C (en) * 1993-05-19 2003-01-28 Akira Nakagawa Solubilizer and external preparations containing the same
CA2169735A1 (en) * 1993-08-17 1995-02-23 Henry C. Caldwell Oral compositions of h2-antagonists
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
JPH09504293A (ja) * 1993-10-28 1997-04-28 ザ、プロクター、エンド、ギャンブル、カンパニー マグネシウムアルミニウムシリケート及び複数の活性成分を含有した速溶解性剤形
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
CA2184361C (en) * 1994-03-24 2000-12-05 Francis Bernard Chapura Solid dose forms containing bismuth
WO1996002262A2 (en) * 1994-07-20 1996-02-01 American Home Products Corporation Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids
US5713131A (en) * 1995-06-30 1998-02-03 The Gillette Company Shaving aid composite with a non-volatile cooling agent
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
US4060091A (en) * 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp 3−l−メントキシプロパン−1、2−ジオ−ル

Also Published As

Publication number Publication date
JPH06506682A (ja) 1994-07-28
DE69205158D1 (de) 1995-11-02
BR9205827A (pt) 1994-06-28
EP0578768B1 (de) 1995-09-27
CA2106215C (en) 1997-05-27
CZ226093A3 (en) 1994-04-13
AU1761492A (en) 1992-11-02
CZ282105B6 (cs) 1997-05-14
AU665349B2 (en) 1996-01-04
EP0578768A1 (de) 1994-01-19
KR100238565B1 (ko) 2000-02-01
HU213203B (en) 1997-03-28
ATE128351T1 (de) 1995-10-15
RU2126249C1 (ru) 1999-02-20
HU9302970D0 (en) 1994-01-28
DE69205158T2 (de) 1996-04-18
HUT65881A (en) 1994-07-28
CA2106215A1 (en) 1992-10-05
ES2077417T3 (es) 1995-11-16
GR3017580T3 (en) 1995-12-31
WO1992017164A1 (en) 1992-10-15
SK121293A3 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
DK0578768T3 (da) Nedsvælgelige farmaceutiske sammensætninger til behandling af lidelse i den øvre del af mavetarmkana len
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
ATE447952T1 (de) Synergistische kombination von pumafentrine und salmeterol
DE69617659D1 (de) Pharmazeutische zusammensetzungen, welche ausgewählte lanthankarbonathydrate enthalten
ATE246681T1 (de) Sulfonamide
NO902280D0 (no) Ny poroes farmasoeytisk form og fremstilling derav.
ATE494002T1 (de) Prävention und/oder behandlung von colitis ulcerosa mit pyy oder pyyä3-36ü
EE9700008A (et) Uus ravimpreparaat valu vaigistamiseks
DE69009684T2 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
DK0470117T3 (da) Anvendelse af "calcitonin gene-related peptides" til fremstilling af lægemidler til behandling af erektile dysfunktioner
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
NO923643D0 (no) Legemiddel for behandling av gastrointestinale forstyrrelser
BR0311898A (pt) Tratamento de associação para depressão e ansiedade com antagonistas de nk1 e nk3
HUP9700660A2 (hu) Alfa1-adrenoreceptor antagonisták felhasználása a prosztata jóindulatú hyperpláziájának megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
DK221690A (da) Anvendelse af dimethylpolysiloxaner til behandling af sygdomme i det gastrointestinale omraade
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
DK0519983T3 (da) Anvendelse af ketorolac til behandling af periodontal sygdom
ATE195868T1 (de) Pharmazeutische zusammensetzungen von gallium- komplexen von 3-hydroxy-4-pyronen
DK0836853T3 (da) Anvendelse af bradykinin-antagonister til fremstilling af lægemidler til behandling og forebyggelse af Alzheimers sygdom
NO982634D0 (no) Sammensetninger inneholdende vismut og ett eller flere antimikrobielle midler for forebygging og behandling av gastrointestinale forstyrrelser
SE9403861D0 (sv) Novel medicinal use
MA23429A1 (fr) Novelle forme galenique de derives de 5-nitro imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus-gastro-intestinal.
DK1007047T3 (da) Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling
DE60126504D1 (de) Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa